Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05392998
Other study ID # 21/365-O_P_Viv
Secondary ID
Status Completed
Phase
First received
Last updated
Start date June 16, 2021
Est. completion date March 9, 2022

Study information

Verified date August 2023
Source Clínica Rementería
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Low amounts of postoperative residual astigmatism may worsen the visual performance of patients implanted with presbyopia- correcting intraocular lenses (IOLs). Although extended depth of focus (EDoF) IOLS have introduced optical improvements, it is important to determine the tolerance of these IOLs to postoperative astigmatism. This is important for an appropriate surgical planning. Therefore, the aim of this study is to simulate and assess the impact of mild amounts of residual mixed astigmatisms with the axis oriented in different positions (vertical, oblique and horizontal) in eyes implanted with the Vivity® IOL.


Description:

Objectives: - Primary objective: To describe the tolerance of simulated astigmatism on patients implanted with Vivity at far distance. - Secondary objective: To describe the tolerance of simulated astigmatism on patients implanted with Vivity at intermediate distance. Study Design: Prospective, single arm, descriptive, 3-month follow up. Patient population: 30 consecutive eyes of 30 patients implanted with Vivity bilaterally with no postoperative complications. The calculation of the required sample size was based on monocular corrected distande visual acuity. A difference of 0.2 logMAR units was assumed to be clinically significant anda standard deviation of 0.05 was anticipated(data obtained from a comparative study between a bifocal and a trifocal IOL: Jonker SM, et al. Journal of Cataract Refract Surg. 2015; 41: 1631-40). Based on these assumptions, with an α of 0.05 and power of 0.8, it was calculated that 25 eyes were required in each group. Due to potential dropouts, a larger sample size has been selected. Clinical Protocol: All patients fullfilling study criteria will be considered for inclusion three months after surgery. After patient consent, uncorrected distance visual acuity will be measured with an ETDRS chart, followed by subjective refraction (best distance correction). In all cases, mixed astigmatism will be induced with trial lens over the best distance corrected situation (considered the reference situation). Once the best distance correction is determined, the different visual acuity evaluation procedures for this study will be performed with a Freiburg Acuity Test software package. The software will be run on a separate laptop screen calibrated to be presented at 4 meters. In this procedure, a black Landolt C is presented to the subjects and, among 8 different possibilities, they indicate the orientation of the optotype on a numeric keypad. This test minimizes the observer's bias because the presented optotype depends on the patient´s previous responses. That is, when the observer responds to a certain optotype, the software automatically modifies the size of the next optotype according to parameter estimation by a sequential test method. (7,8) Finally, all serious adverse events will be reported. Statistical Analysis: Visual acuity values will be expressed as mean and standard deviation. Normal distribution of variables will be assessed using the Kolmogorov- Smirnov test. Pre- and post-operative data of each parameter will be compared by means of the Student's t-test. A repeated measure analysis of variance (ANOVA) will be used to gauge any statistically significant difference of the data within the different simulated situations. Differences are considered to be statistically significant for P value <0.05 (i.e., at the 5% level).


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date March 9, 2022
Est. primary completion date March 9, 2022
Accepts healthy volunteers No
Gender All
Age group 40 Years to 90 Years
Eligibility Inclusion Criteria: - Patients >40 years old that undergo routine cataract surgery - Bilateral implantation of Vivity ® IOL Exclusion Criteria: - Corneal astigmatism =1.0 diopters (D ) - Amblyopia - Previous ocular surgery - Presence of ocular pathologies - Abnormal iris - Patients with intra- or postoperative complications - Postoperative best distance corrected visual acuity (BDCVA) < 20/20 - Postoperative refractive astigmatism > 0.50D

Study Design


Related Conditions & MeSH terms


Intervention

Device:
Cataract surgery with Vivity intraocular lens implantation
Cataract surgery with Vivity intraocular lens implantation

Locations

Country Name City State
Spain Clínica Rementería Madrid

Sponsors (2)

Lead Sponsor Collaborator
Clínica Rementería Alcon Research

Country where clinical trial is conducted

Spain, 

Outcome

Type Measure Description Time frame Safety issue
Primary Distance Against the Rule Astimatism Change from baseline condition in the monocular best corrected distance visual acuity, inducing astigmatism of +0.25-0.50x0*, taking as a reference the subjects' axis Three months after surgery
Primary Distance Oblique Astigmatism Change from baseline condition in the monocular best corrected distance visual acuity, inducing astigmatism of +0.25-0.50x45*, taking as a reference the subjects' axis Three months after surgery
Primary Distance With the Rule Astigmatism Change from baseline condition in the monocular best corrected distance visual acuity, inducing astigmatism of +0.25-0.50x90*, taking as a reference the subjects' axis Three months after surgery
See also
  Status Clinical Trial Phase
Recruiting NCT00563277 - Surgical Treatment of Concurrent Cataract and Primary Pterygium N/A
Completed NCT03512626 - Clinical Evaluation of Multifocal Intraocular Lens: OPTIVIS.TM N/A
Enrolling by invitation NCT05392738 - Visual Function and Patient Satisfaction in Glaucoma or Ocular Hypertensive Patients Undergoing Simultaneous Cataract Surgery and i-Stent Implantation
Recruiting NCT04916041 - Visual Function in Subjects Implanted With Advanced Technology Intraocular Lenses
Withdrawn NCT03505827 - Visual Field Changes in TECNIS ZCB00 Monofocal vs. TECNIS Symfony Extended Depth of Focus Intraocular Lens Implantation
Completed NCT01202981 - Impact of Glistenings in AcrySof Intraocular Lenses on Visual Quality N/A
Recruiting NCT05827133 - Effect of Intraocular Lens (IOL) Centration and Tilt on Visual Performance With Clareon® Vivity® IOL Implantation
Completed NCT04059289 - Intermediate Vision in a Driving Simulator Environment: Comparison of the J&J EYHANCE With a Conventional Monofoc. IOL
Completed NCT05430295 - Visual Acuity After Using A New Monofocal Intraocular Lens Compared To Standard Monofocal Lens N/A
Completed NCT05431868 - Objective and Subjective Outcomes of a Trifocal IOL in Eyes With Different AL
Completed NCT01873781 - A Pilot Study Simulating Multifocal Intraocular Lenses in Healthy Subjects N/A